| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1748 |
| Trial ID | NCT03191773 |
| Disease | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies |
| Year | 2017 |
| Country | China |
| Company sponsor | Second Affiliated Hospital of Guangzhou Medical University |
| Other ID(s) | 2017-HS-32 |
| Cohort 1 | |||||||||||
|
|||||||||||